Publications by authors named "Bo-da Zhou"
Objective: To evaluate the effectiveness and safety of oral Chinese herbal medicines (CHMs) on post-percutaneous coronary intervention (PCI) patients with depressive disorder in coronary heart disease (CHD).
Methods: A literature search was conducted through databases including PubMed, Cochrane Library, Chinese National Knowledge Infrastructure Databases (CNKI), Chinese Biomedical Literature Database (SinoMed), Chongqing VIP Chinese Science and Technology Periodical Database (VIP) and Wanfang Database up to August 2018. Randomized controlled trials (RCTs) comparing CHMs with placebo or no additional treatments on the basis of standard conventional pharmacological therapies were included.
Article Synopsis
- The study analyzed reasons why patients underwent emergency coronary angiography (CAG) but did not receive percutaneous coronary intervention (PCI), focusing on 201 patients in a single-center retrospective approach.
- Among the non-PCI patients, 26% were diagnosed with conditions other than coronary heart disease, while treatments varied from drug therapy to bypass surgery, based on the severity of their coronary issues.
- The GRACE score was found to be an effective tool for predicting PCI possibilities, as patients who received PCI had significantly higher scores compared to those who did not, with a strong predictive capability demonstrated in the analysis.